Global Gastric Cancer Therapy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Therapy Type;

Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy and Surgery.

By End User;

Ambulatory Surgery Centers, Hospitals and Specialty Clinics and Other End users.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn454686160 Published Date: March, 2025 Updated Date: April, 2025
Download Free Sample NowDownload Free Sample Now

Introduction

Global Gastric Cancer Therapy Market (USD Million), 2021 - 2031

In the year 2024, the Global Gastric Cancer Therapy Market was valued at USD 9,290.89 million. The size of this market is expected to increase to USD 16,957.95 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.0%.

The global gastric cancer therapy market has been growing steadily as a result of the increasing incidence of gastric cancer worldwide. Gastric cancer, often referred to as stomach cancer, is one of the leading causes of cancer-related deaths, particularly in regions such as East Asia, Europe, and parts of South America. With a significant rise in risk factors such as smoking, poor diet, and the infection caused by Helicobacter pylori bacteria, the need for effective treatments has become more critical. Advancements in medical technology, combined with the increased focus on early diagnosis and targeted therapies, have led to improved survival rates and better management options for patients.

The gastric cancer therapy market includes a broad spectrum of treatment options, ranging from traditional chemotherapy and radiation therapy to newer approaches such as immunotherapy and targeted therapy. Chemotherapy, despite its side effects, continues to be a cornerstone in the treatment of advanced gastric cancer. However, emerging therapies are playing an increasingly important role in the management of gastric cancer. Targeted therapies, which aim to attack cancer cells more specifically while minimizing damage to healthy cells, are gaining traction due to their improved efficacy and reduced toxicity. Immunotherapies, which harness the body's immune system to fight cancer, are also being integrated into treatment regimens and have shown promising results in clinical trials.

As research into the molecular and genetic aspects of gastric cancer continues to evolve, personalized medicine is becoming a significant trend in the field. Biomarkers are being studied for their potential in identifying patients who would benefit most from specific therapies, enabling more tailored treatment plans. Additionally, there is growing emphasis on combination therapies, where multiple treatment modalities are used simultaneously to achieve better outcomes. The expansion of clinical trials and the ongoing development of new drugs and therapeutic approaches are expected to drive market growth in the coming years. Despite these advancements, challenges such as late-stage diagnosis, high treatment costs, and side effects of treatments remain critical issues that need to be addressed for improving patient outcomes on a global scale.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Therapy Type
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Gastric Cancer Therapy Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Burden of Gastric Cancer
        2. Introduction of Novel Therapies for Metastatic Stomach Cancer
      2. Restraints
        1. High Cost of Cancer Therapy and Side Effects of Cancer Drugs
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Gastric Cancer Therapy Market, By Therapy Type, 2023 - 2033 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2025 and 2031 (%)
      3. Y-o-Y Growth Analysis, 2022 - 2031
      4. Segment Trends
        1. Chemotherapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2031 (USD Million)
        2. Targeted Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2031 (USD Million)
        3. Immunotherapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2031 (USD Million)
        4. Radiation Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2031 (USD Million)
        5. Surgery
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2031 (USD Million)
    2. Global Gastric Cancer Therapy Market, By End User, 2023 - 2033 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2025 and 2031 (%)
      3. Y-o-Y Growth Analysis, 2022 - 2031
      4. Segment Trends
        1. Ambulatory Surgery Centers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2031 (USD Million)
        2. Hospitals and Specialty Clinics
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2031 (USD Million)
        3. Other End users
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2021 - 2031 (USD Million)
    3. Global Gastric Cancer Therapy Market, By Geography, 2023 - 2033 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2025 and 2031 (%)
      3. Y-o-Y Growth Analysis, 2022 - 2031
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2031 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2031 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Eli Lilly and Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Pfizer Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. F. Hoffmann-La Roche Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Merck & Co. Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Celltrion Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market
Download Free Sample NowDownload Free Sample Now